BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 18334847)

  • 1. Sensitivity of mesenchymal stem cells and their progeny to medicines used for the treatment of hematoproliferative diseases.
    Nifontova I; Svinareva D; Petrova T; Drize N
    Acta Haematol; 2008; 119(2):98-103. PubMed ID: 18334847
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impaired differentiation potential of human trabecular bone mesenchymal stromal cells from elderly patients.
    Coipeau P; Rosset P; Langonne A; Gaillard J; Delorme B; Rico A; Domenech J; Charbord P; Sensebe L
    Cytotherapy; 2009; 11(5):584-94. PubMed ID: 19626496
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Isolation of human mesenchymal stromal cells is more efficient by red blood cell lysis.
    Horn P; Bork S; Diehlmann A; Walenda T; Eckstein V; Ho AD; Wagner W
    Cytotherapy; 2008; 10(7):676-85. PubMed ID: 18985474
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of adjuvant chemotherapy on bone marrow mesenchymal stem cells of colorectal cancer patients.
    Cao J; Tan MH; Yang P; Li WL; Xia J; Du H; Tang WB; Wang H; Chen XW; Xiao HQ
    Cancer Lett; 2008 May; 263(2):197-203. PubMed ID: 18304729
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reactive oxygen species produced in mitochondria are involved in age-dependent changes of hematopoietic and mesenchymal progenitor cells in mice. A study with the novel mitochondria-targeted antioxidant SkQ1.
    Shipounova IN; Svinareva DA; Petrova TV; Lyamzaev KG; Chernyak BV; Drize NI; Skulachev VP
    Mech Ageing Dev; 2010 Jun; 131(6):415-21. PubMed ID: 20600239
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Study on the improvement of bone marrow microenvironment by ligustrazine in immune-induced aplastic anemia mice].
    Sun H; Shu Y; Liu W
    Zhonghua Xue Ye Xue Za Zhi; 1998 Apr; 19(4):178-80. PubMed ID: 11243129
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mesenchymal stem cells remain host-derived independent of the source of the stem-cell graft and conditioning regimen used.
    Bartsch K; Al-Ali H; Reinhardt A; Franke C; Hudecek M; Kamprad M; Tschiedel S; Cross M; Niederwieser D; Gentilini C
    Transplantation; 2009 Jan; 87(2):217-21. PubMed ID: 19155975
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mesenchymal stromal cells lose their immunosuppressive potential after allotransplantation.
    Prigozhina TB; Khitrin S; Elkin G; Eizik O; Morecki S; Slavin S
    Exp Hematol; 2008 Oct; 36(10):1370-6. PubMed ID: 18619727
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative characterization of bone marrow-derived mesenchymal stromal cells from four different rat strains.
    Barzilay R; Sadan O; Melamed E; Offen D
    Cytotherapy; 2009; 11(4):435-42. PubMed ID: 19521891
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro effect of captopril and three captopril metabolites on neutrophilic progenitor cells from normal mice and mice given busulfan.
    Boyd RL; Erslev AJ; Caro J
    J Lab Clin Med; 1984 Jul; 104(1):44-50. PubMed ID: 6376669
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Results of a pilot study on the use of third-party donor mesenchymal stromal cells in cord blood transplantation in adults.
    Gonzalo-Daganzo R; Regidor C; Martín-Donaire T; Rico MA; Bautista G; Krsnik I; Forés R; Ojeda E; Sanjuán I; García-Marco JA; Navarro B; Gil S; Sánchez R; Panadero N; Gutiérrez Y; García-Berciano M; Pérez N; Millán I; Cabrera R; Fernández MN
    Cytotherapy; 2009; 11(3):278-88. PubMed ID: 19308773
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Survival of human mesenchymal stromal cells from bone marrow and adipose tissue after xenogenic transplantation in immunocompetent mice.
    Niemeyer P; Vohrer J; Schmal H; Kasten P; Fellenberg J; Suedkamp NP; Mehlhorn AT
    Cytotherapy; 2008; 10(8):784-95. PubMed ID: 18951271
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Properties and potential of bone marrow mesenchymal stromal cells from children with hematologic diseases.
    Dimitriou H; Linardakis E; Martimianaki G; Stiakaki E; Perdikogianni CH; Charbord P; Kalmanti M
    Cytotherapy; 2008; 10(2):125-33. PubMed ID: 18368591
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dynamic distribution of bone marrow-derived mesenchymal stromal cells and change of pathology after infusing into mdx mice.
    Feng SW; Lu XL; Liu ZS; Zhang YN; Liu TY; Li JL; Yu MJ; Zeng Y; Zhang C
    Cytotherapy; 2008; 10(3):254-64. PubMed ID: 18418771
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterisation and developmental potential of ovine bone marrow derived mesenchymal stem cells.
    McCarty RC; Gronthos S; Zannettino AC; Foster BK; Xian CJ
    J Cell Physiol; 2009 May; 219(2):324-33. PubMed ID: 19115243
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Calcification or dedifferentiation: requirement to lock mesenchymal stem cells in a desired differentiation stage.
    Dickhut A; Pelttari K; Janicki P; Wagner W; Eckstein V; Egermann M; Richter W
    J Cell Physiol; 2009 Apr; 219(1):219-26. PubMed ID: 19107842
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multiparametric comparison of mesenchymal stromal cells obtained from trabecular bone by using a novel isolation method with those obtained by iliac crest aspiration from the same subjects.
    Sanchez-Guijo FM; Blanco JF; Cruz G; Muntion S; Gomez M; Carrancio S; Lopez-Villar O; Barbado MV; Sanchez-Abarca LI; Blanco B; Briñon JG; del Cañizo MC
    Cell Tissue Res; 2009 Jun; 336(3):501-7. PubMed ID: 19357871
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adipocyte differentiation defect in mesenchymal stromal cells of patients with malignant infantile osteopetrosis.
    Uckan D; Kilic E; Sharafi P; Kazik M; Kaya F; Erdemli E; Can A; Tezcaner A; Kocaefe C
    Cytotherapy; 2009; 11(4):392-402. PubMed ID: 19337938
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Selection of CD271(+) cells and human AB serum allows a large expansion of mesenchymal stromal cells from human bone marrow.
    Poloni A; Maurizi G; Rosini V; Mondini E; Mancini S; Discepoli G; Biasio S; Battaglini G; Felicetti S; Berardinelli E; Serrani F; Leoni P
    Cytotherapy; 2009; 11(2):153-62. PubMed ID: 19301169
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human bone marrow mesenchymal stem cells accelerate recovery of acute renal injury and prolong survival in mice.
    Morigi M; Introna M; Imberti B; Corna D; Abbate M; Rota C; Rottoli D; Benigni A; Perico N; Zoja C; Rambaldi A; Remuzzi A; Remuzzi G
    Stem Cells; 2008 Aug; 26(8):2075-82. PubMed ID: 18499895
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.